| P50 | author | Luis M Blanco-Colio | Q55542660 |
| P2093 | author name string | Jean-Baptiste Michel | |
| | Jesus Egido | |
| | Olivier Meilhac | |
| | Luis Miguel Blanco-Colio | |
| | Jose Luis Martín-Ventura | |
| | Carmen Gomez-Guerrero | |
| | Jose Tunon | |
| P2860 | cites work | The human plasma proteome: a nonredundant list developed by combination of four separate sources | Q24304465 |
| | Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime | Q28212769 |
| | The human plasma proteome: history, character, and diagnostic prospects | Q28218148 |
| | Mortality by cause for eight regions of the world: Global Burden of Disease Study | Q29615121 |
| | Atherosclerosis. the road ahead | Q29618972 |
| | Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues | Q30662372 |
| | Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics | Q30824394 |
| | Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction | Q30978394 |
| | Prefractionation techniques in proteome analysis: the mining tools of the third millennium | Q30980895 |
| | Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression | Q31044253 |
| | Proteomic patterns of tumour subsets in non-small-cell lung cancer | Q31154301 |
| | Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis | Q33204658 |
| | HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples | Q33220604 |
| | Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identificati | Q33220605 |
| | Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma | Q33222110 |
| | Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands | Q33223472 |
| | Differential exoprotease activities confer tumor-specific serum peptidome patterns | Q33230965 |
| | Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy. | Q33233052 |
| | Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure | Q33234723 |
| | SELDI-TOF MS analysis of the Cardiac Troponin I forms present in plasma from patients with myocardial infarction | Q33262047 |
| | New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry. | Q33262471 |
| | Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis | Q33271663 |
| | Investigating diversity in human plasma proteins | Q33905685 |
| | Protease degradomics: a new challenge for proteomics | Q34136618 |
| | Tissue microarray technology for high-throughput molecular profiling of cancer | Q34188970 |
| | C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease | Q34311841 |
| | Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 |
| | Neovascularization in human atherosclerosis | Q34523545 |
| | Biomarkers of cardiovascular disease: molecular basis and practical considerations | Q34526561 |
| | Progression of atheroma: a struggle between death and procreation | Q34858516 |
| | The macrophage foam cell as a target for therapeutic intervention | Q34986351 |
| | Stabilization of atherosclerotic plaques: new mechanisms and clinical targets | Q34986368 |
| | Candidate-based proteomics in the search for biomarkers of cardiovascular disease | Q35990040 |
| | Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage | Q36204124 |
| | Quest for novel cardiovascular biomarkers by proteomic analysis. | Q36219610 |
| | Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer. | Q36414618 |
| | C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients | Q36456535 |
| | Population proteomics: the concept, attributes, and potential for cancer biomarker research | Q36492806 |
| | Biology of atherosclerotic plaques: what we are learning from proteomic analysis | Q36524948 |
| | Biomarkers in cardiovascular disease: integrating pathophysiology into clinical practice | Q36619158 |
| | Cardiovascular proteomics: tools to develop novel biomarkers and potential applications | Q36644478 |
| | The pathogenesis of coronary artery disease and the acute coronary syndromes (1). | Q36728740 |
| | Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics | Q40493491 |
| | Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? | Q40572496 |
| | Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold | Q40899284 |
| | National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report | Q44016317 |
| | Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice | Q44485950 |
| | Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study | Q46505779 |
| | Role of N-terminal pro-B-type natriuretic peptide in risk stratification in patients presenting in the emergency room | Q46668016 |
| | Metabolomic identification of novel biomarkers of myocardial ischemia | Q46847927 |
| | Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide | Q48630098 |
| | Profiling of differential protein expression in angiogenin-induced HUVECs using antibody-arrayed ProteoChip. | Q51588779 |
| | A neural network aid for the early diagnosis of cardiac ischemia in patients presenting to the emergency department with chest pain. | Q52027802 |
| | CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease | Q57154282 |
| P433 | issue | 2 | |
| P304 | page(s) | 249-260 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | Expert Review of Proteomics | Q15749465 |
| P1476 | title | Proteomics in atherothrombosis: a future perspective | |
| P478 | volume | 4 | |